Scleroderma: Causes, Risk Factors, and Pathophysiology
Scleroderma (systemic sclerosis) is an autoimmune connective tissue disease of unknown exact cause. Pathogenesis involves immune dysregulation, vasculopathy, and fibrosis.
Contributing Factors
- Genetic: HLA associations (DRB1*11, DPB1*13); family history increases risk.
- Environmental: Silica dust, organic solvents, vinyl chloride, welding fumes.
- Hormonal: Female predominance (4:1); onset often perimenopausal.
- Autoimmune overlap: Associated with lupus, rheumatoid arthritis, Sjögren's.
- Infectious triggers: Hypothesized (e.g., CMV, parvovirus B19) but unproven.
Two main subsets: limited cutaneous (CREST syndrome) and diffuse cutaneous. Early diagnosis by a rheumatologist enables organ-based screening (pulmonary fibrosis, pulmonary arterial hypertension, renal crisis, GI dysmotility) and targeted therapy (immunosuppressants, vasodilators, antifibrotics).
Multiple Sclerosis - Related Articles
- Managing Multiple Sclerosis Symptoms: Exploring Complementary Therapies
- Scurvy: Vitamin C Deficiency Causes, Symptoms & Risk Groups
- Sclerotherapy Procedure: Step-by-Step Guide
- Ask the Advocate: Securing Support for Living with Multiple Sclerosis
- Understanding Sensory Symptoms in Multiple Sclerosis (MS)
- Understanding the Link Between Multiple Sclerosis and Neuropathic Pain
- Multiple Sclerosis and Oligodendrocytes: The Target of Autoimmune Attack
